Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Dupilumab Injection
DRUG
3 trials
Sponsors
National Medical Research Center for Children's Health, Russian Federation
, Gan & Lee Pharmaceuticals.
, Innovent Biologics (Suzhou) Co. Ltd.
Conditions
Atopic Dermatitis
Biosimilarity
Congenital Ichthyosis
Phase 1
A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects
Not yet recruiting
NCT07334496
Gan & Lee Pharmaceuticals.
Biosimilarity
Start: 2026-03-09
End: 2026-07-17
Target: 198
Updated: 2026-01-12
Phase 3
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis
Not yet recruiting
NCT07754786
Innovent Biologics (Suzhou) Co. Ltd.
Atopic Dermatitis
Start: 2026-10-20
End: 2028-08-26
Target: 520
Updated: 2026-08-10
Phase 4
Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children
NCT04996485
National Medical Research Center for Children's Health, Russian Federation
Congenital Ichthyosis
Start: 2021-03-01
End: 2023-06-01
Target: 50
Updated: 2021-08-09